Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Analgesic Efficiency of SIPSPB vs ICNB in VATS Surgery

24. august 2026 oppdatert av: Abdullah Bozkurt, Kocaeli City Hospital

Comparison Of The Analgesic Effectiveness Of Ultrasonography-Guided Serratus Posterıor Superior Intercostal Plane (SPSIP) Block And Intercostal Nerve (ICN) Block In Video-Assisted Thoracoscopic Surgery Patients

This study aims to evaluate the effectiveness of Serratus Posterior Superior Intercostal Plane (SPSIP) block compared to Intercostal Nerve (ICN) block in terms of postoperative pain control, reduction of opioid analgesic consumption, minimization of postoperative respiratory complications, and increase patient satisfaction (using a 5-point Likert scale) in patients undergoing video-assisted thoracoscopic surgery (VATS).

Studieoversikt

Status

Fullført

Forhold

Detaljert beskrivelse

In this prospective observational study, patients included in the study will receive Serratus Posterior Superior Intercostal Plane (SPSIP) block and Intercostal Nerve (ICN) block for postoperative analgesia at the end of surgery. The SPSIP block will be performed by the anesthesiologist under ultrasound guidance immediately after skin closure and before extubation, while the ICN block will be performed by the surgeon under direct vision immediately before skin closure.

At the end of surgery, patients will receive 1000 mg paracetamol and 50 mg dexketoprofen during skin closure. Upon arrival at the recovery room, each patient will be connected to a patient-controlled analgesia (PCA) pump containing tramadol. At postoperative reassessment, patients with a Numerical Pain Rating Scale (NPRS) score greater than 4 despite PCA use will receive a rescue analgesic dose of 50 mg dexketoprofen.

Postoperative pain intensity will be assessed using the NPRS (Numerical Pain Rating Scale) at 1, 4, 6, 12, 18, and 24 hours postoperatively, both at rest and during coughing. Total opioid consumption, rescue analgesic use, and postoperative complications will be recorded.

Patients will be informed about their level of surgical satisfaction 24 hours after surgery, and this information will be recorded.

Studietype

Observasjonsmessig

Registrering (Faktiske)

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Tyrkia (Türkiye)
- - İzmit, Tyrkia (Türkiye)
    - Kocaeli City Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

Voksen
Eldre voksen

Tar imot friske frivillige

Nei

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

Patients who will undergo elective VATS surgery in the thoracic surgery operating room of Kocaeli City Hospital

Beskrivelse

Inclusion Criteria:

Aged 18-80 years,
American Society of Anesthesiologists (ASA) physical status I-III
Patients who have provided informed consent to participate in the study

Exclusion Criteria:

Patients who refuse to participate in the study by not signing the informed consent
Patients classified as ASA > 3, according to the system established by the American Society of Anesthesiologists
Patients unable to understand the use of the NPR Scale or the PCA device that will be used for postoperative analgesia
Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
Patients with allergies to analgesic and/or anesthetic drugs
Infection at the block injection site
Patients whose surgical procedure is intraoperatively converted to an open pulmonary resection

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Antall grupper / kohorter

Kohorter og intervensjoner

Gruppe / Kohort
Group SPSIP Block In patients meeting the inclusion criteria for the study, an ultrasound-guided interfacial plane block is applied between the posterior superior serratus muscle and the underlying ribs in patients undergoing SPSIP block after VATS.
Group ICN Block Patients meeting the inclusion criteria for the study who will undergo intercostal nerve block after VATS will have a total of 10 ml of 0.5% bupivacaine applied to two segments (upper and lower segments of the incision line) under direct vision by the surgeon while the patient is in the lateral decubitus position at the end of the operation and immediately before skin closure.

Hva måler studien?

Primære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Postoperative pain intensity Tidsramme: 24 hours after the end of surgery	In both study groups, postoperative pain intensity at rest and with coughing was measured using the Numerical Pain Rating Scale (NPRS), a numerical scale ranging from 0 to 10 (0 meaning no pain, 10 meaning the most severe pain imaginable).	24 hours after the end of surgery

Sekundære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Pasienttilfredshetsscore Tidsramme: 24 timer etter operasjonen	evaluert ved hjelp av en 5-punkts Likert-skala (1=veldig misfornøyd, 5=veldig fornøyd)	24 timer etter operasjonen
Total opioid drug consumption Tidsramme: 24 hours after the end of surgery	The total amount of opioid doses administered via a Patient Controlled Analgesia (PCA) device in the first 24 hours after surgery	24 hours after the end of surgery
Consumption of rescue analgesics Tidsramme: 24 hours after the end of surgery	The total dose of dexketoprofen required by the patient during each specified time interval in the first 24 hours after surgery.	24 hours after the end of surgery
Postoperative Complications Tidsramme: 24 hours after the end of surgery	Postoperative complications such as nausea, vomiting or other adverse events will be recorded	24 hours after the end of surgery

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Kocaeli City Hospital

Etterforskere

Studieleder: Ayşe Z Turan Cıvraz, Assoc. Prof., Kocaeli City Hospital

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

18. mai 2026

Primær fullføring (Faktiske)

1. august 2026

Studiet fullført (Faktiske)

5. august 2026

Datoer for studieregistrering

Først innsendt

5. mai 2026

Først innsendt som oppfylte QC-kriteriene